+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Latin America, Middle East & Africa Urinary Incontinence Devices Market (2018 - 2024)

  • ID: 4721656
  • Report
  • November 2018
  • Region: Latin America, Middle East, Africa
  • 101 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Atlantic Therapeutics
  • B. Braun Melsungen AG
  • C. R. Bard, Inc.
  • Coloplast Group
  • Medtronic plc
  • Teleflex Incorporated
  • MORE
The Latin America, Middle East and Africa Urinary Incontinence Devices Market is expected to witness market growth of 12.8% CAGR during the forecast period (2018 - 2024). Urinary incontinence is an unintentional leakage of urine, and it is differentiated into four types, namely, stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence. Urinary incontinence is most commonly found in women. Development of innovative urinary catheters, growing preference for surgical treatment for urinary incontinence is the factors that drive the growth of the market during the forecast period. In addition, rise in geriatric population that normally suffers from urinary incontinence or incontinence associated with chronic conditions (kidney stones, miscarriages, paralysis, and neuromuscular injury) is expected to be a factor that is expected to drive the market growth.

Based on product, the market report segments the market into Vaginal Slings, Urinary Catheters, Electrical Stimulation Devices, Artificial Urinary Sphincters, and Other Devices. The category segment includes External Urinary Incontinence Devices and Internal Urinary Incontinence Devices. The Incontinence Type segment covers Stress Incontinence, Urge Incontinence, Overflow Incontinence, and Functional Incontinence. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include C. R. Bard, Inc., Boston Scientific Corporation, Coloplast Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), B. Braun Melsungen AG, Teleflex Incorporated, Atlantic Therapeutics, and Zephyr Surgical Implants
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Atlantic Therapeutics
  • B. Braun Melsungen AG
  • C. R. Bard, Inc.
  • Coloplast Group
  • Medtronic plc
  • Teleflex Incorporated
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Urinary Incontinence Devices Market, by Product
1.4.2 LAMEA Urinary Incontinence Devices Market, by Category
1.4.3 LAMEA Urinary Incontinence Devices Market, by Incontinence Type
1.4.4 LAMEA Urinary Incontinence Devices Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Urinary Incontinence Devices Market by Product
3.1.1 LAMEA Vaginal Slings Market by Country
3.1.2 LAMEA Urinary Incontinence Devices Market by Vaginal Slings Type
3.1.2.1 LAMEA Conventional Vaginal Slings Market by Country
3.1.2.2 LAMEA Advanced Vaginal Slings Market by Country
3.1.3 LAMEA Urinary Catheters Market by Country
3.1.4 LAMEA Urinary Incontinence Devices Market by Urinary Catheters Type
3.1.4.1 LAMEA Foley Catheters Market by Country
3.1.4.2 LAMEA Other Urinary Catheters Market by Country
3.1.5 LAMEA Electrical Stimulation Devices Market by Country
3.1.6 LAMEA Artificial Urinary Sphincters Market by Country
3.1.7 LAMEA Other Devices Market by Country

Chapter 4. LAMEA Urinary Incontinence Devices Market by Category
4.1.1 LAMEA Internal Urinary Incontinence Devices Market by Country
4.1.2 LAMEA External Urinary Incontinence Devices Market by Country

Chapter 5. LAMEA Urinary Incontinence Devices Market by Incontinence Type
5.1.1 LAMEA Stress Incontinence Market by Country
5.1.2 LAMEA Urge Incontinence Market by Country
5.1.3 LAMEA Overflow Incontinence Market by Country
5.1.4 LAMEA Functional Incontinence Market by Country

Chapter 6. LAMEA Urinary Incontinence Devices Market by Country
6.1 Brazil Urinary Incontinence Devices Market
6.1.1 Brazil Urinary Incontinence Devices Market by Product
6.1.1.1 Brazil Urinary Incontinence Devices Market by Vaginal Slings Type
6.1.1.2 Brazil Urinary Incontinence Devices Market by Urinary Catheters Type
6.1.2 Brazil Urinary Incontinence Devices Market by Category
6.1.3 Brazil Urinary Incontinence Devices Market by Incontinence Type
6.2 Argentina Urinary Incontinence Devices Market
6.2.1 Argentina Urinary Incontinence Devices Market by Product
6.2.1.1 Argentina Urinary Incontinence Devices Market by Vaginal Slings Type
6.2.1.2 Argentina Urinary Incontinence Devices Market by Urinary Catheters Type
6.2.2 Argentina Urinary Incontinence Devices Market by Category
6.2.3 Argentina Urinary Incontinence Devices Market by Incontinence Type
6.3 UAE Urinary Incontinence Devices Market
6.3.1 UAE Urinary Incontinence Devices Market by Product
6.3.1.1 UAE Urinary Incontinence Devices Market by Vaginal Slings Type
6.3.1.2 UAE Urinary Incontinence Devices Market by Urinary Catheters Type
6.3.2 UAE Urinary Incontinence Devices Market by Category
6.3.3 UAE Urinary Incontinence Devices Market by Incontinence Type
6.4 Saudi Arabia Urinary Incontinence Devices Market
6.4.1 Saudi Arabia Urinary Incontinence Devices Market by Product
6.4.1.1 Saudi Arabia Urinary Incontinence Devices Market by Vaginal Slings Type
6.4.1.2 Saudi Arabia Urinary Incontinence Devices Market by Urinary Catheters Type
6.4.2 Saudi Arabia Urinary Incontinence Devices Market by Category
6.4.3 Saudi Arabia Urinary Incontinence Devices Market by Incontinence Type
6.5 South Africa Urinary Incontinence Devices Market
6.5.1 South Africa Urinary Incontinence Devices Market by Product
6.5.1.1 South Africa Urinary Incontinence Devices Market by Vaginal Slings Type
6.5.1.2 South Africa Urinary Incontinence Devices Market by Urinary Catheters Type
6.5.2 South Africa Urinary Incontinence Devices Market by Category
6.5.3 South Africa Urinary Incontinence Devices Market by Incontinence Type
6.6 Nigeria Urinary Incontinence Devices Market
6.6.1 Nigeria Urinary Incontinence Devices Market by Product
6.6.1.1 Nigeria Urinary Incontinence Devices Market by Vaginal Slings Type
6.6.1.2 Nigeria Urinary Incontinence Devices Market by Urinary Catheters Type
6.6.2 Nigeria Urinary Incontinence Devices Market by Category
6.6.3 Nigeria Urinary Incontinence Devices Market by Incontinence Type
6.7 Rest of LAMEA Urinary Incontinence Devices Market
6.7.1 Rest of LAMEA Urinary Incontinence Devices Market by Product
6.7.1.1 Rest of LAMEA Urinary Incontinence Devices Market by Vaginal Slings Type
6.7.1.2 Rest of LAMEA Urinary Incontinence Devices Market by Urinary Catheters Type
6.7.2 Rest of LAMEA Urinary Incontinence Devices Market by Category
6.7.3 Rest of LAMEA Urinary Incontinence Devices Market by Incontinence Type

Chapter 7. Company Profiles
7.1 Medtronic Plc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 C.R. Bard, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Boston Scientific Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expense
7.4 Coloplast Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 B. Braun Melsungen AG.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental Analysis
7.5.4 Research & Development Expense
7.6 Johnsons & Johnsons
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Regional Analysis
7.6.5 Research & Development Expense
7.7 Teleflex Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Segmental Analysis
7.7.5 Research & Development Expense
7.8 Atlantic Therapeutics Ltd.
7.8.1 Company Overview
7.9 Zephyr Surgical Implants (ZSI)
7.9.1 Company Overview
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • C. R. Bard, Inc.
  • Boston Scientific Corporation
  • Coloplast Group
  • Medtronic plc
  • Ethicon US, LLC. (Johnson & Johnson)
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • Atlantic Therapeutics
  • Zephyr Surgical Implants
Note: Product cover images may vary from those shown
Adroll
adroll